The COALA
Heart Monitor System

COALA is a unique medical innovation based on more than 10 years of R&D, with more than 20 patents and over 15 industry awards.

A device and cloud-based solution including a high-performance stethoscope, three integrated electrodes to capture diagnostic-quality ECG and smart algorithms enabling real-time analysis of data.

Schedule a demo today.

See for yourself why hundreds of clinics and thousands of patients use Coala. Fill out the form to schedule a free demo customized for your clinic's specific needs

COALA is powered by a unique patented digital technology resulting in industry leading diagnostic-quality ECG.

The dual ECG recording with noise suppression maximizes quality, accuracy, and reduces artifacts. The smart algorithms detect AF based on P-waves and RR-dispersion leading to a significant reduced rate of false positives and increased overall accuracy.

The COALA is a CE and FDA 510(k) cleared device supported by strong clinical data with thousands of users. The chest-ECG with synchronized heart sound recording and thumb-ECG is transmitted via Bluetooth to maximize quality, precision and accuracy - with less artifacts and minimized false positives.

COALA’s smart algorithms analyze the recordings based on pattern recognition, P-waves and RR variability. Conventional 1-lead ECGs typically only detect AF based on RR variability, which result in high false positives. The COALA has been proven to be 300% more accurate than standard 1-lead ECG solutions, typically used in watches and other portable ECG’s.

State-of-the-art 1,000 Hz and 24-bit ECG digital architecture and data analyzed by high-performance cloud-based platform.

The HIPAA-compliant Coala Care portal presents data in real-time to providers and includes a smart report generator with ability to manually annotate and download raw data for further analysis.

Published data has not only proved high sensitivity and specificity for the system, but also a PPV of 87% for automatic AF detection.

COALA has an integrated stethoscope that captures heart sounds. During ECG recordings, the heart sound is recorded and synchronized with the chest measurement. The data is presented as a digital phonocardiogram (PCG) to aid the detection of murmurs.

Heart sounds can also be listened to remotely and downloaded from the Coala Care portal.

The COALA is designed for real-time remote monitoring of heart and lungs. Real-time ECG analysis with integrated stethoscope enabling remote auscultation of heart and lungs.

Prescribe as a 30-day Event Monitor or as a long-term Remote Patient Monitor (RPM) up to a year. No waiting for results with on demand ECG reports.

Ideal for telemedicine services with ability to enroll in the clinic or in the safety of the patient’s home.

The COALA is ideal to prescribe to patients with palpitations and intermittent symptoms of possible arrhythmias that need a long-term monitoring solution.

Its unique dual-lead ECG solution captures accurate, clinically relevant cardiac data when symptoms occur. It’s the only smartphone-based solution with automatic AF detection based on advanced pattern recognition algorithms.

The real-time visibility to results ensures physicians can efficiently progress symptomatic patients along the treatment path.

The COALA can also be used for remote monitoring of lung sounds from a patient’s home. The unique stethoscope and respiratory monitoring solution is available with support of FDA’s Emergency Guidance during the COVID-19 public health emergency.

Easy to enroll patient’s directly from their homes, eliminating the need of physical visits. Data is transmitted in real-time, making COALA ideal for Telemedicine use.

The COALA is a unique 2-in-1 solution that can be prescribed as an Event Monitor (billed globally as CPT 93268) and/or used to follow patients long-term in RPM programs and billed monthly (CPT 99453, 99454, 99457 and 99458).

The COALA is available for Home Enrollment, where it’s shipped direct to the patient enabling virtual cardiac diagnostics and eliminating physical patient visits.

The COALA was used in the groundbreaking RedHeart Study by the Karolinska Institute (Stockholm, Sweden) and included nearly 1,000 women and over 280,000 ECG recordings in everyday life. The study showed an increase in quality of life in women with palpitations, because of the instant results that helped reduce symptoms, anxiety and depression.

The COALA is currently used in multiple clinical studies including the TEASE-study on cryptogenic stroke patients. The COALA is provided to patients to help detect AF post-admission for an extended period of time at home. Results to be presented in 2020.